Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

7.56
BATS BZX Real-Time Price
As of 12:23pm ET
 -0.17 / -2.20%
Today’s Change
6.19
Today|||52-Week Range
13.04
-17.65%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$557.5M

Company Description

Inovio Pharmaceuticals, Inc. is revolutionizing the fight against cancer and infectious diseases. Its immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Contact Information

Inovio Pharmaceuticals, Inc.
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462
P:(267) 440-4200
Investor Relations:
(858) 410-3101

Employees

Shareholders

Individual stakeholders5.69%
Mutual fund holders16.91%
Other institutional16.25%

Top Executives

J. Joseph KimPresident, Chief Executive Officer & Director
Niranjan Y. SardesaiChief Operating Officer
Peter D. KiesChief Financial Officer
Jessica LeeVice President-Clinical Operations & Compliance
Mark L. BagarazziChief Medical Officer